Eyebright Medical(SH:688050)2026-01-21 02:05Summary of the Conference Call Record Company Overview - Company Name: 德美医疗 (Demei Medical) - Industry Focus: Specializes in "Sports Medicine + Sports Health" as a technology-driven enterprise - Business Scope: Covers the entire chain from "preoperative prevention to surgical treatment to postoperative rehabilitation" - Product Range: 1. Sports medicine implants 2. Surgical tools 3. Arthroscopic equipment 4. Sports rehabilitation devices and equipment 5. Research, production, sales, and services - Industry Position: Leading enterprise in the domestic industry - Procurement Qualification: Selected for the National High-Value Medical Consumables Procurement Group A [1] Acquisition Details - Valuation of Target Company: Expected to be no more than RMB 1 billion - Final Transaction Price: To be determined based on asset appraisal report and due diligence results - Acquisition Stake: At least 51% equity - Acquisition Goal: To gain control of the target company [1] Financial Performance (Last Three Years) - Revenue Growth: - 2023: RMB 178 million - 2024: RMB 236 million - 2025: RMB 286 million - Net Profit (Adjusted): - 2023: Loss of RMB 7.08 million - 2024: Profit of RMB 9.29 million - 2025: Profit of RMB 23.60 million [1]